News | Cardiac Imaging | June 07, 2019

Amsterdam University Medical Center Wins MR Solutions' Image of the Year Award

Competition had leading academics evaluate MRI, PET, CT and combination images from MR Solutions users around the world

A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.


June 7, 2019 — The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular research image. Preclinical image submissions came in from most of MR Solutions’ users across the world. The winners, which were presented at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, May 11-16 in Montreal, QC, Canada, were chosen by a panel of leading academics who examined images from magnetic resonance imaging (MRI), positron emission tomography (PET) or computed tomography (CT) – or a combination of imaging modalities.

The winning submission was carried out by Amsterdam Ph.D. researcher Gustav Strijkers. This technique was used in cardiac research to produce a high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse (figure 1). The exceptional quality and accuracy of the cardiomyopathy research significantly advances the preclinical imaging sector in the battle to better understand heart muscle disease and treatment.

The submission from Sydney Imaging Core Research Facility came a close second place for the high-quality MR abdominal image of a pregnant Sprague Dawley rat (figure 2). The resulting image showed multiple embryonic implants and was ranked for image clarity, research interpretation and understanding.

The third place submission by the Centre Georges François Leclerc centre in France was a PET-MR whole body image of an eight-week-old BALB/c mouse showing a CT26 xenograft tumor (figure 3). This displayed a clear breakdown of the metabolic, hypoxic and necrotic regions of the tumor. Additional axial images showed further localized information on the high and low uptake areas of 18F-FMISO using a 2T signal.

For more information: www.mrsolutions.com


Related Content

News | Cardiac Imaging

Jan. 6, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
News | Cardiac Imaging

Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...

Home January 13, 2026
Home
News | Cardiac Imaging

Jan. 7, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has partnered with Jefferson Health, one ...

Home January 08, 2026
Home
News | Cardiac Imaging

Dec. 12, 2025 — Increased volume of epicardial adipose tissue, detected by cardiovascular imaging, was found to be ...

Home January 02, 2026
Home
News | Cardiac Imaging

Dec. 11 2025 — Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients ...

Home December 17, 2025
Home
News | Cardiac Imaging

Nov. 30, 2025 – Ascend Cardiovascular, a provider of purpose-built enterprise imaging for cardiology, and Konica Minolta ...

Home December 09, 2025
Home
News | Cardiac Imaging

Dec. 1, 2025 — Cleerly, a provider of AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025 ...

Home December 02, 2025
Home
News | Cardiac Imaging

Nov. 30, 2025 — KA Imaging Technology has announced that its Reveal 35C detector with SpectralDR technology will be ...

Home December 01, 2025
Home
News | Cardiac Imaging

Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens ...

Home November 14, 2025
Home
News | Cardiac Imaging

Oct. 1, 2025 – Intelerad has announced the next generation of InteleHeart, a reimagined, all-in-one cardiology platform ...

Home October 02, 2025
Home
Subscribe Now